| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |